Nov 9, 2020 02:00AM
Nov 11, 2019 02:00AM
Apr 25, 2019 07:07AM
Apr 9, 2019 02:00AM
Mar 26, 2019 03:00AM
Mar 25, 2019 03:00AM
Mar 21, 2019 03:00AM Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director
Mar 4, 2019 02:00AM
Feb 28, 2019 02:00AM
Feb 26, 2019 02:00AM
Feb 20, 2019 02:00AM
Feb 4, 2019 02:00AM
Jan 14, 2019 02:00AM
Jan 9, 2019 08:10AM Powershares Variable Rate Preferred Portfolio (VRP) Announces WHO Approval for 'ensifentrine' as Recommended INN for RPL554
Jan 9, 2019 08:00AM
Jan 3, 2019 02:00AM
Dec 17, 2018 02:00AM
Nov 6, 2018 02:00AM
Oct 31, 2018 03:00AM
Oct 30, 2018 02:00AM
Oct 26, 2018 05:12AM Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference
Sep 27, 2018 02:00AM
Sep 13, 2018 08:00AM
Sep 12, 2018 02:00AM
Sep 6, 2018 02:00AM
Aug 7, 2018 02:00AM
Aug 1, 2018 02:00AM
Jul 26, 2018 08:30AM Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2018 and Provide Clinical Development Update
Jul 24, 2018 08:30AM
May 30, 2018 08:30AM
May 23, 2018 02:00AM
May 21, 2018 05:15PM
May 9, 2018 08:30AM
May 8, 2018 02:00AM
May 4, 2018 08:30AM Verona Pharma to Present at Bio€quity Europe 2018
May 2, 2018 08:30AM
Apr 11, 2018 02:00AM
Mar 26, 2018 02:00AM
Mar 15, 2018 08:00AM
Mar 2, 2018 02:00AM
Feb 27, 2018 02:00AM
Feb 22, 2018 08:45AM Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017
Feb 13, 2018 02:00AM
Nov 30, 2017 08:42AM
Nov 7, 2017 02:00AM
Nov 7, 2017 02:00AM
Oct 31, 2017 03:00AM
Oct 31, 2017 02:55AM
Sep 27, 2017 02:00AM Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients
Sep 7, 2017 02:00AM

41,487 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All